“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Illumina currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are IDEXX ...

Scientists have unveiled a new way to capture ultra-sharp optical images without lenses or painstaking alignment. The ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

The "In Situ Hybridization Market Report by Product, Technique, Application, End User, Countries and Company Analysis ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...